Recruiting at 1 site No phase Long COVID

Long COVID study: Acute Intermittent Hypoxia

Official title Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog

ClinicalTrials.gov ID: NCT06614309

What this study is testing

What it's testing
The study will see how short‑term and long‑term low‑oxygen or high‑CO₂ conditions affect symptoms of long‑COVID.
Who it's for
Adults who have long‑COVID with brain fog.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • English speaking
  • Diagnosis of Long COVID

You likely can't join if

  • Coronary artery dissection or aortic dissection
  • Neurological disease (e.g. dementia, Alzheimer's disease, or other brain-related disease)
  • Cerebrovascular disease or stroke
  • Aneurysm
  • Moderate-severe chronic obstructive pulmonary disease
  • Uncontrolled moderate-severe asthma
See the full eligibility criteria
Who can join
  • English speaking
  • Diagnosis of Long COVID
What rules you out
  • Coronary artery dissection or aortic dissection
  • Neurological disease (e.g. dementia, Alzheimer's disease, or other brain-related disease)
  • Cerebrovascular disease or stroke
  • Aneurysm
  • Moderate-severe chronic obstructive pulmonary disease
  • Uncontrolled moderate-severe asthma
  • Moderate-severe bronchiectasis
  • Moderate-severe interstitial lung disease, requiring the use of supplemental oxygen
  • A necessity to use supplemental oxygen, for any reason
  • New or worsening symptoms (decompensation) of heart failure
  • Right heart disease due to chronic pulmonary disease/sleep apnea
  • Uncontrolled myocardial ischemia or angina
  • Uncontrolled heart arrhythmias
  • Heart or lung infection (e.g. myocarditis or pericarditis)
  • Left main coronary artery stenosis
  • Moderate-severe aortic stenosis
  • Pulmonary embolism, pulmonary infarction, or other blood clots
  • Severe respiratory disease
  • Chronic kidney disease
  • Chronic liver disease
  • Females of childbearing potential will complete a urine pregnancy test at their baseline visit to rule out pregnancy
  • BMI \>40
  • Study staff unable to obtain adequate signal for cerebral blood flow

The study team makes the final eligibility decision.

Where it is enrolling

  • Scottsdale, Arizona, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Scottsdale, Arizona, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.